Safety evaluation of endometrial biopsy aiming to analyze ERA/EMMA/ALICE for patient with repeated IVF failure, recurrent pregnancy losses and chronic endometritis.
Conditions
Interventions
Sponsors
Tohoku university
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Patient with repeated IVF failure, recurrent pregnancy losses and chronic endometritis.
Exclusion criteria
Exclusion criteria: (1)Patient who dose not fulfill inclusion criteria (2)Patient who dose not agree with study participation (3)Patient who are receiving treatment for endometrial hyperplasia or endometrial cancer (4)Patient who have difficulty for endometrial biopsy due to congenital mullerian duct anomaly, Bleeding tendency and/or who requires hospital admission for anesthesia. (5)Patient who are pregnant or suspicious of pregnancy (6)Patient who have psychosomatic problem and have been decided to difficult to participant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of complication related to endometrial biopsy for ERA/EMMA/ALICE. | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of ERA/EMMA/ALICE test suitability of biopsied endometrial samples | — |
Countries
Japan
Contacts
Public ContactMasahito Tachibana
Tohoku university graduate school of medicine Department of perinatology
Outcome results
None listed